CDTX vs ROL · rev $1.3M vs P/E 41, rev $3.39B
Cidara Therapeutics Inc (CDTX) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
CDTX currently screens at market cap $6.96B. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the CDTX and ROL stock pages for the full models.
Not investment advice.